NEW YORK, Oct. 11, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities

http://www.reportlinker.com/p01009930/Molecular-Imaging-Agents-Targets-Technology-Markets-and-Commercial-Opportunities.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care. Targetable and activatable imaging agents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. The number of healthcare conditions that can be effectively imaged noninvasively is expanding as a result of these innovative detection technologies. Targeted and activatable imaging agents offer a unique capability to generate unambiguous images by exploiting specific molecular targets, pathways or cellular processes. This new wave of imaging agents signals a paradigm shift in which the reagents take on new importance.

Highlights

Analyzes and assesses emerging imaging diagnostic candidates, their capabilities, benefits, limitations and potential

Profiles development-stage imaging agents and examines their clinical status and commercial prospects

Analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets

Profiles market participants, their development activity and business strategies

Read more here:

Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities